Philippe Bierling
- Hematology top 0.1%
- Blood groups and transfusion 88
- Platelet Disorders and Treatments 77
- Genetics top 0.5%
- Blood disorders and treatments 20
- Chronic Lymphocytic Leukemia Research 13
- Biochemistry top 2%
- Nephrology top 2%
- Renal Diseases and Glomerulopathies 13
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 13
-
- Erythrocyte Function and Pathophysiology 23
-
- Autoimmune Bullous Skin Diseases 19
- Co-authors
- Bertrand GodeauMarc MichelMehdi KhellafAnnette SchaefferPatricia FromontN. DuédariÉric OksenhendlerF. Noizat‐Pirenne
- Cited by
- HematologyGeneticsBiochemistry
- Partner nations
- FranceUnited StatesTunisia
In The Last Decade
Philippe Bierling
158 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 113
- Hematology 3.8k
- Genetics 1.2k
- Biochemistry 309
- Nephrology 333
- Immunology 935
Countries citing papers authored by Philippe Bierling
This map shows the geographic impact of Philippe Bierling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Bierling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Bierling more than expected).
Fields of papers citing papers by Philippe Bierling
This network shows the impact of papers produced by Philippe Bierling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Bierling. The network helps show where Philippe Bierling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Bierling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 17 | |
| 2 | 2014 | 9 | |
| 3 | 2014 | 8 | |
| 4 | 2013 | 6 | |
| 5 | 2012 | 243 | |
| 6 | 2010 | 8 | |
| 7 | [What are the rules and regulations for blood product transfusion in France?]. | 2009 | 3 |
| 8 | Que reste-t-il des risques infectieux des produits sanguins? | 2009 | 1 |
| 9 | 2009 | 6 | |
| 10 | 2008 | 184 | |
| 11 | 2008 | 54 | |
| 12 | 2005 | 7 | |
| 13 | Transfusion de concentrés plaquettaires | 1998 | 0 |
| 14 | 1997 | 1 | |
| 15 | Purpura thrombopénique idiopathique | 1995 | 1 |
| 16 | 1994 | 32 | |
| 17 | Influence of posttransplantation blood transfusion on kidney allograft survival: a one-center, double-blind, prospective, randomized study comparing cryopreserved and fresh red blood cell concentrates. | 1993 | 2 |
| 18 | [Double liver-kidney transplantation in the presence of a positive T cross-match]. | 1992 | 3 |
| 19 | 1992 | 35 | |
| 20 | 1987 | 67 |
About Philippe Bierling
Philippe Bierling is a scholar working on Hematology, Transplantation, Genetics, Nephrology and Management of Technology and Innovation, having authored 165 papers that have together received 5.3k indexed citations. Recurring topics across this work include Blood groups and transfusion (88 papers), Platelet Disorders and Treatments (77 papers), Erythrocyte Function and Pathophysiology (23 papers), Blood disorders and treatments (20 papers), Autoimmune Bullous Skin Diseases (19 papers), Chronic Lymphocytic Leukemia Research (13 papers), Renal Diseases and Glomerulopathies (13 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). The work is most often cited by research in Hematology (3.8k citations), Genetics (1.2k citations), Biochemistry (309 citations), Nephrology (333 citations) and Immunology (935 citations). Philippe Bierling has collaborated with scholars based in France, United States and Tunisia. Frequent co-authors include Bertrand Godeau, Marc Michel, Mehdi Khellaf, Annette Schaeffer, Patricia Fromont, N. Duédari, Éric Oksenhendler, F. Noizat‐Pirenne, Catherine Cordonnier and Frédéric Galactéros. Their work appears in journals such as Transfusion, Blood, British Journal of Haematology, Vox Sanguinis and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.